News

Flagship Launches Etiome with $50M to Use AI for Stage-Specific Drug Target Discovery

Flagship Pioneering has launched Etiome, a biotechnology start-up focused on identifying and drugging biomarkers that correspond to specific stages of …

Continue ›››

Twist Bioscience Spins Out Atlas Data Storage with $155M to Commercialize DNA-Based Data Storage

Twist Bioscience has launched Atlas Data Storage as an independent company focused entirely on the development and commercialization of DNA …

Continue ›››

Lantern Pharma Advances AI-Guided Drug into Phase 1b/2 Trial for Triple Negative Breast Cancer

Lantern Pharma announced FDA clearance of its Investigational New Drug (IND) application for LP-184 in the treatment of triple negative …

Continue ›››

Recursion Reports Positive Early Trial Results for Familial Adenomatous Polyposis

Recursion has released early results from its ongoing Phase 1b/2 TUPELO trial evaluating REC-4881, an investigational MEK1/2 inhibitor, as a …

Continue ›››

Nurix Debuts Foundation Model to Predict Novel Binders for Undruggable Targets

Nurix Therapeutics presented new data at the 2025 AACR Annual Meeting supporting the capabilities of its DEL-AI platform—a machine learning–powered …

Continue ›››

Eli Lilly Partners with Creyon Bio in up to $1B AI-Oligonucleotide Deal

Eli Lilly has signed a strategic partnership with Creyon Bio to develop AI-designed oligonucleotide therapeutics, committing $13 million upfront and up …

Continue ›››

NIH Launches Initiative to Prioritize Human-Based Research Technologies

The National Institutes of Health (NIH) has launched a new initiative to expand the use of human-based research technologies while …

Continue ›››

Axiom Bio Launches with $15M to Replace Animal Testing with AI for Drug Toxicity Prediction

San Francisco-based startup founded by Brandon White and Alex Beatson has announced $15 million in seed funding from Amplify Partners, …

Continue ›››

Raidium Publishes Promptable CT Foundation Model for Tumor Segmentation

Raidium, a Paris-based medical AI company founded in 2022 by radiologist Dr. Paul Hérent and data scientist Pierre Manceron, focuses …

Continue ›››

Tempus Introduces Loop, an AI-Driven Platform for Target Discovery and Validation

Tempus AI, Inc. (NASDAQ: TEM) announced the launch of Tempus Loop, a proprietary oncology-focused platform designed to streamline target discovery …

Continue ›››

NHS Wales Pilots Paige AI Tool to Triage Cancer Cases

Paige and NHS Wales have launched a pilot project at Betsi Cadwaladr University Health Board (BCUHB) to evaluate the clinical …

Continue ›››

Immunai and Parker Institute to Build Largest Single-Cell Dataset for Real-World Immunotherapy Research

Immunai and the Parker Institute for Cancer Immunotherapy (PICI) have announced a collaboration to build what they describe as the …

Continue ›››